By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Other immunostimulants > Nirsevimab
Other immunostimulants

Nirsevimab

https://themeditary.com/drug/nirsevimab-8326.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 29, 2023  Additional Content by TheMediTary.Com

Generic name: nirsevimab [ nir-sev-i-mab ]

Drug class: Other immunostimulants

Dosage form: intramuscular solution (alip preservative-free 100 mg/ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Beyfortus, Nirsevimab (cvx 306), Beyfortus (cvx 307), Beyfortus (cvx 306)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Nirsevimab?

Nirsevimab is a man-made antibody that helps protect the body against respiratory syncytial virus (RSV) infection for up to 5 months.

Nirsevimab is used to prevent lung disease caused by respiratory syncytial virus in newborn baby and children up to 24 months old.

Nirsevimab may also be used for purposes not listed in this medication guide.

Warnings

Nirsevimab should not be given to a child who has had a severe allergic reaction to it.

Your child should not receive a medicine called palivizumab if the child already received nirsevimab in the same respiratory syncytial virus (RSV) season.

How should I take Nirsevimab

Nirsevimab is given once as an injection (shot) into the leg muscle. A healthcare provider will give this injection.

If your child remains at increased risk for getting RSV infection or has heart surgery, your child may receive another dose of this medicine.

Dosing information

Usual Pediatric Dose for Respiratory Syncytial Virus:

Recommended dosage:
-Neonate and infants born during or entering their first respiratory syncytial virus (RSV) season: 50 mg intramuscularly once (for children less than 5 kg) or 100 mg intramuscularly once (for children 5 kg or greater)

-Children up to 24 months of age who remain at increased risk for severe RSV in their second RSV season: a single 200 mg dose intramuscularly, administered as two 100 mg injections (2 x 100 mg).

-Children undergoing cardiac surgery with cardiopulmonary bypass: an additional dose is recommended via intramuscular route as soon as the child is stable after surgery to ensure adequate vaccine serum levels.
--In the first RSV season: If surgery is within 90 days after receiving the vaccine, the additional dose should be based on current body weight. See above for body weight dosing. If more than 90 days have elapsed since receiving the vaccine, the additional dose should be 50 mg regardless of body weight.
--In the second RSV season: If surgery is within 90 days after receiving the vaccine, the additional dose should be 200 mg, regardless of body weight. If more than 90 days have elapsed since receiving the vaccine, the additional dose should be 100 mg regardless of body weight.

Use: For active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates and infants born during or entering their first RSV season and children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.

Detailed Nirsevimab dosage information
Nirsevimab Dosage information (more detail)

Before Taking

Your child should not receive nirsevimab if the child has ever had a life-threatening allergic reaction to any component of nirsevimab or to antibodies called immunoglobulins.

Your child should not receive a medicine called palivizumab if the child already received nirsevimab in the same RSV season.

Tell your child's doctor if the child has bleeding or bruising problems.

What happens if I miss a dose?

Nirsevimab is used as a single dose and does not have a daily dosing schedule.

What happens if I overdose?

An overdose of nirsevimab is unlikely to occur.

What should I avoid while using Nirsevimab?

Follow the doctor's instructions about any restrictions on food, beverages, or activity.

Nirsevimab side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of the face, lips, tongue, or throat.

Call the doctor at once if your child has:

  • muscle weakness;

  • trouble swallowing;

  • blue lips or fingernails; or

  • bluish color of skin.

Common side effects of nirsevimab may include:

  • hard painful lump (induration) around where the medicine was injected; or

  • rash, or swelling where the injection was given.

This is not a complete list of side effects and others may occur. Call your child's doctor for medical advice about side effects. You may report side effects to FDA at 1 800 FDA 1088.

See more: Nirsevimab Side Effects

What other drugs will affect Nirsevimab?

Other drugs may affect nirsevimab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell the doctor about all other medicines your child uses.

More about Nirsevimab (Nirsevimab [ nir-sev-i-mab ])

Dosage information
Nirsevimab Side Effects
During pregnancy
Drug images
Side effects
Drug class: Other immunostimulants

Related treatment guides

Respiratory Syncytial Virus
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by